Abstract Background Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. Method In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were ...
© 2017 Elsevier B.V. and International Society of Chemotherapy Clinical midstream and urinary cathet...
CANWARD against fosfomycin by using the Clinical and Laboratory Standards Institute (CLSI) agar dilu...
Fosfomycin has become a therapeutic option in urinary tract infections. Our objective was to evaluat...
Urinary tract infections (UTIs) are prevalent worldwide, particularly among women. Their incidence i...
Introduction: Urinary tract infection (UTI) is one of the most common clinical entities encountered ...
We evaluated the in vitro activity of fosfomycin against urinary isolates in a region in Greece that...
Introduction: Urinary tract infection (UTI) is one of the most common infectious diseases. With the ...
Aim To determine in vitro susceptibility of multiresistant bacterial isolates to fosfomycin. Methods...
BackgroundUrinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing E...
The antimicrobial susceptibility testing of 284 Enterobacteriaceae isolates responsible for urinary ...
Background: As a result of extensive use of fluroquinlones and cephalosporins, urinary tract pathoge...
Background and objective: Urinary tract infection(UTI) is one of the most common bacterial infection...
Introduction: In our country and the world, susceptibility of uropathogenic Escherichia coli strains...
PURPOSE: With an increase in the numbers of bacterial isolates resistant to first-line antibiotics, ...
Fosfomycin (FOS) has been recently reintroduced into clinical practice, but its effectiveness agains...
© 2017 Elsevier B.V. and International Society of Chemotherapy Clinical midstream and urinary cathet...
CANWARD against fosfomycin by using the Clinical and Laboratory Standards Institute (CLSI) agar dilu...
Fosfomycin has become a therapeutic option in urinary tract infections. Our objective was to evaluat...
Urinary tract infections (UTIs) are prevalent worldwide, particularly among women. Their incidence i...
Introduction: Urinary tract infection (UTI) is one of the most common clinical entities encountered ...
We evaluated the in vitro activity of fosfomycin against urinary isolates in a region in Greece that...
Introduction: Urinary tract infection (UTI) is one of the most common infectious diseases. With the ...
Aim To determine in vitro susceptibility of multiresistant bacterial isolates to fosfomycin. Methods...
BackgroundUrinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing E...
The antimicrobial susceptibility testing of 284 Enterobacteriaceae isolates responsible for urinary ...
Background: As a result of extensive use of fluroquinlones and cephalosporins, urinary tract pathoge...
Background and objective: Urinary tract infection(UTI) is one of the most common bacterial infection...
Introduction: In our country and the world, susceptibility of uropathogenic Escherichia coli strains...
PURPOSE: With an increase in the numbers of bacterial isolates resistant to first-line antibiotics, ...
Fosfomycin (FOS) has been recently reintroduced into clinical practice, but its effectiveness agains...
© 2017 Elsevier B.V. and International Society of Chemotherapy Clinical midstream and urinary cathet...
CANWARD against fosfomycin by using the Clinical and Laboratory Standards Institute (CLSI) agar dilu...
Fosfomycin has become a therapeutic option in urinary tract infections. Our objective was to evaluat...